↓ Skip to main content

Dove Medical Press

Article Metrics

Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
2 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
2 Mendeley
Title
Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
Published in
Neuropsychiatric Disease and Treatment, August 2018
DOI 10.2147/ndt.s167129
Pubmed ID
Authors

Pu Zhi, Yanqiong Wang, Wei Quan, Yanli Su, Hui Zhang

Abstract

Hyperprolactinemia is a common side effect of antipsychotic drugs. Although changes of antipsychotic drugs or reduction of their doses can solve this problem, a modification of the treatment regimen can lead to instability in patients. Herein, we followed up a patient with elevated prolactin caused by paliperidone and found that the prolactin level was decreased after the administration of a combination with a low-dose aripiprazole. In addition, we summarized and analyzed the findings from the case and the literature review conducted.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 100%
Student > Master 1 50%
Researcher 1 50%
Readers by discipline Count As %
Unspecified 2 100%
Social Sciences 1 50%
Medicine and Dentistry 1 50%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2018.
All research outputs
#7,249,016
of 12,559,973 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,059
of 2,134 outputs
Outputs of similar age
#138,732
of 270,970 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#17
of 58 outputs
Altmetric has tracked 12,559,973 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,134 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 270,970 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.